AQR Capital Management - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$1,275,000
+513.0%
18,720
+164.0%
0.00%
Q4 2021$208,000
-51.4%
7,091
-45.8%
0.00%
-100.0%
Q2 2021$428,000
+84.5%
13,080
+130.1%
0.00%
Q1 2021$232,000
-14.4%
5,684
-10.0%
0.00%
Q4 2020$271,000
-16.9%
6,313
+5.7%
0.00%
-100.0%
Q3 2020$326,000
-85.4%
5,974
-83.1%
0.00%
-75.0%
Q2 2020$2,231,000
+13.1%
35,344
-8.4%
0.00%
+33.3%
Q1 2020$1,972,000
+24.0%
38,599
+93.0%
0.00%
+50.0%
Q4 2019$1,590,000
+109.5%
20,003
+27.9%
0.00%
+100.0%
Q3 2019$759,000
+22.2%
15,643
+32.5%
0.00%0.0%
Q2 2019$621,000
+80.5%
11,807
+40.7%
0.00%
Q4 2018$344,000
-54.3%
8,390
-57.6%
0.00%
-100.0%
Q3 2018$753,000
-12.8%
19,806
+3.7%
0.00%0.0%
Q2 2018$864,000
-33.6%
19,108
-29.1%
0.00%0.0%
Q1 2018$1,302,000
+54.1%
26,963
+25.5%
0.00%0.0%
Q4 2017$845,000
+59.1%
21,476
+25.5%
0.00%0.0%
Q3 2017$531,000
+35.5%
17,114
+19.5%
0.00%0.0%
Q2 2017$392,000
+95.0%
14,323
+163.2%
0.00%
Q1 2017$201,0005,4420.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Grace Capital 177,414$14,103,00011.50%
Fernwood Investment Management, LLC 258,012$20,509,0009.81%
Perceptive Advisors 5,865,726$466,266,0009.26%
ArchPoint Investors 186,756$14,845,0004.54%
STANSBERRY ASSET MANAGEMENT, LLC 115,638$9,192,0003.74%
Camber Capital Management LP 730,000$58,028,0002.95%
Profit Investment Management, LLC 46,873$3,726,0002.50%
Casdin Capital, LLC 300,000$23,847,0002.19%
SECTORAL ASSET MANAGEMENT INC 174,594$13,878,0002.07%
Corriente Advisors, LLC 40,000$3,180,0001.71%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders